Education
About Us
Working with TipRanks
Follow Us
OrganiGram Holdings (TSE:OGI)
:OGI
OGI Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$1.22 - C$2.72
Previous CloseN/A
Volume112.96K
Average Volume (3M)151.63K
Market Cap
C$295.52M
Enterprise ValueC$169.62M
Total Cash (Recent Filing)C$36.78M
Total Debt (Recent Filing)C$9.15M
Price to Earnings (P/E)73.3
Beta2.32
Next Earnings
Dec 02, 2025EPS Estimate
>-0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.05
Shares Outstanding134,325,580
10 Day Avg. Volume159,009
30 Day Avg. Volume151,631
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
C$2.50Price Target Upside13.60% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Bulls Say, Bears Say
Bulls Say
Financial PerformanceAdjusted gross margin expanded sequentially to 34.2%, moving closer to management’s fiscal 2025 target of ~35% as synergy capture and product mix improvements continue.
Market ExpansionOrganigram announced its entry into the U.S. market through the acquisition of Collective Project Limited for upfront consideration of $6.2M.
Revenue GrowthOrganigram reported Q3/F25 net revenue of $70.8M, compared to our estimate of $69.0M and consensus of $68.0M, representing an increase of 72.4% Y/Y, largely as a result of the Motif acquisition.
Bears Say
Acquisition CostsThe structure of the deal with an upfront payment, along with contingent consideration based on milestones provides OGI with a relatively low-risk acquisition with upside should the revenue growth that is projected materialize.
Balance Sheet ImpactThe last tranche from BAT closed during the quarter that added $41.5M on the balance sheet.
OrganiGram Holdings News
OGI FAQ
What was OrganiGram Holdings’s price range in the past 12 months?
OrganiGram Holdings lowest stock price was C$1.22 and its highest was C$2.72 in the past 12 months.
What is OrganiGram Holdings’s market cap?
OrganiGram Holdings’s market cap is C$295.52M.
When is OrganiGram Holdings’s upcoming earnings report date?
OrganiGram Holdings’s upcoming earnings report date is Dec 02, 2025 which is in 87 days.
How were OrganiGram Holdings’s earnings last quarter?
OrganiGram Holdings released its earnings results on Aug 13, 2025. The company reported -C$0.05 earnings per share for the quarter, missing the consensus estimate of -C$0.011 by -C$0.039.
Is OrganiGram Holdings overvalued?
According to Wall Street analysts OrganiGram Holdings’s price is currently Undervalued.
Does OrganiGram Holdings pay dividends?
OrganiGram Holdings does not currently pay dividends.
What is OrganiGram Holdings’s EPS estimate?
OrganiGram Holdings’s EPS estimate is >-0.01.
How many shares outstanding does OrganiGram Holdings have?
OrganiGram Holdings has 134,325,580 shares outstanding.
What happened to OrganiGram Holdings’s price movement after its last earnings report?
OrganiGram Holdings reported an EPS of -C$0.05 in its last earnings report, missing expectations of -C$0.011. Following the earnings report the stock price went down -0.45%.
Which hedge fund is a major shareholder of OrganiGram Holdings?
Currently, no hedge funds are holding shares in TSE:OGI
OrganiGram Holdings Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
C$2.50 (13.60% Upside)
C$2.50 (13.60% Upside)
Blogger Sentiment
Bullish
TSE:OGI Sentiment 70%
Sector Average 70%
Sector Average 70%
Insider Transactions
Sold Shares
Worth $146.9K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▲ 0.2%
Last 30 Days ▼ 4.0%
Last 30 Days ▼ 4.0%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-10.55%
12-Months-Change
Fundamentals
Return on Equity
1.86%
Trailing 12-Months
Asset Growth
59.61%
Trailing 12-Months
Company Description
OrganiGram Holdings
OrganiGram Holdings Inc. is a leading Canadian cannabis company based in Moncton, New Brunswick. It specializes in the production and sale of high-quality cannabis products, including dried flower, oils, and pre-rolls. With a focus on innovation and sustainability, OrganiGram operates in the regulated cannabis sector, catering to both the medical and recreational markets. The company is committed to delivering premium cannabis products that meet the evolving needs of consumers while adhering to strict quality and safety standards.
OGI Company Deck
OGI Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
Organigram reported a strong quarter with record-breaking revenue and significant market share in Canada, supported by international expansion and operational improvements. However, challenges with ERP integration and delays in EU GMP certification presented some setbacks. Despite these challenges, the company's positive cash flow and strategic initiatives suggest a strong long-term trajectory.View all TSE:OGI earnings summariesOGI Stock 12 Month Forecast
Average Price Target
C$2.50
▲(13.60% Upside)
Technical Analysis
Canopy Growth
―
Aurora Cannabis
―
Cronos Group
―
Curaleaf Holdings
―
Trulieve Cannabis
―
Ownership Overview
10.53% Insiders
0.03%
Mutual Funds
0.89% Other Institutional Investors
85.19% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---